Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Top Cited Papers
Open Access
- 31 December 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 25 (1), 121-130
- https://doi.org/10.1177/0269881110379283
Abstract
Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. However, no study to date has investigated the effects of this compound on human pathological anxiety and its underlying brain mechanisms. The aim of the present study was to investigate this in patients with generalized social anxiety disorder (SAD) using functional neuroimaging. Regional cerebral blood flow (rCBF) at rest was measured twice using (99m)Tc-ECD SPECT in 10 treatment-naive patients with SAD. In the first session, subjects were given an oral dose of CBD (400 mg) or placebo, in a double-blind procedure. In the second session, the same procedure was performed using the drug that had not been administered in the previous session. Within-subject between-condition rCBF comparisons were performed using statistical parametric mapping. Relative to placebo, CBD was associated with significantly decreased subjective anxiety (p < 0.001), reduced ECD uptake in the left parahippocampal gyrus, hippocampus, and inferior temporal gyrus (p < 0.001, uncorrected), and increased ECD uptake in the right posterior cingulate gyrus (p < 0.001, uncorrected). These results suggest that CBD reduces anxiety in SAD and that this is related to its effects on activity in limbic and paralimbic brain areas.Keywords
This publication has 93 references indexed in Scilit:
- Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1AreceptorsBritish Journal of Pharmacology, 2010
- 5‐HT1A receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratsBritish Journal of Pharmacology, 2008
- Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependenceJournal of Psychiatric Research, 2008
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific PhobiaAmerican Journal of Psychiatry, 2007
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitroBritish Journal of Pharmacology, 2007
- Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing picturesNeuroscience Letters, 2005
- Brain activation to phobia-related words in phobic subjectsNeuroscience Letters, 2004
- The problem of functional localization in the human brainNature Reviews Neuroscience, 2002
- The hypnotic effect of propofol in the medial preoptic area of the ratLife Sciences, 2001